eMedicine Specialties > General Surgery > Abdomen

Splenic Infarct

Manish Parikh, MD, Assistant Professor of Surgery, Department of Surgery, New York University School of Medicine; Attending Surgeon, Director Laparoscopic and Bariatric Surgery, Bellevue Hospital
H Leon Pachter, MD, FACS, Chair, George David Stewart Professor, Department of Surgery, New York University Medical Center

Updated: Jan 16, 2009

Introduction

Splenic infarction refers to occlusion of the splenic vascular supply, leading to parenchymal ischemia and subsequent tissue necrosis. The infarct may be segmental, or it may be global, involving the entire organ. It is the result of arterial or venous compromise and is associated with a heterogeneous group of diseases. Splenic infarction alone is not an indication for surgery. However, nonoperative management warrants close follow-up, and surgery is indicated for persistent symptoms or in the presence of complications such as hemorrhage, rupture, abscess, or persistent pseudocyst.

History of the Procedure

One of the earliest descriptions of splenic infarct was made in Germany in 1896, after a splenic infarction was seen microscopically following splenectomy for endocarditis (presumably due to septic emboli).¹

Frequency

Often a clinically silent condition, splenic infarct is associated most commonly with hematologic disorders. Although splenic infarct rates of 50% and 72% have been reported in chronic myelogenous leukemia and myelofibrosis, respectively, few large series describing this entity exist. In 1998, Nores and colleagues²  reported 59 cases treated over a 30-year period at the University of California, Los Angeles (UCLA), and at the Cedars-Sinai Medical Center. In 1986, Jaroch and coauthors³  identified 75 patients through clinical or autopsy reports at the Cleveland Clinic and found only an additional 77 cases in the literature. Most of the current literature consists of case reports only.

The frequency of visualized splenic infarcts may be rising because of the following factors:

• The increased radiologic imaging of patients (with subsequent increased incidental detection of splenic infarcts)⁴
• The current standard of nonoperative management of blunt splenic injuries
• The increased use of angiographic embolization for vascular splenic injuries (see images below and Images 1-3)⁵

Splenic infarct. Computed tomography scan of a 51-year-old man following a motor vehicle accident. American Association for the Surgery of Trauma (AAST) grade III splenic injury, with active extravasation of contrast from the splenic parenchyma (the white area along the medial aspect of the spleen).

Splenic infarct. Selective splenic arteriogram showing extravasation of contrast from the splenic artery at the splenic hilum prior to angioembolization (see Image 3).

Computed tomography scan of the spleen 5 days after angioembolization of a bleeding splenic artery, showing partial splenic infarct (demonstrated by a lack of IV contrast enhancement of the lower pole of spleen). The patient experienced no adverse sequelae and fared well following his discharge to home 5 days after the embolization (see Image 2).

Etiology

There are numerous etiologies of splenic infarct. The vast majority (88%), however, are either infiltrative hematologic diseases that cause congestion of the splenic circulation by abnormal cells, or thromboembolic conditions that produce obstruction of larger vessels.²  The etiologies of splenic infarct are as follows:

• Malignant hematologic disorders
  • Leukemia
  • Lymphoma (ie, Hodgkin, non-Hodgkin)
  • Myelofibrosis
• Benign hematologic disorders
  • Hypercoagulable states - Protein C or protein S deficiency, oral contraceptives, lupus anticoagulant
  • Erythropoietin therapy
  • Idiopathic venous thrombosis
  • Polycythemia vera
  • Sickle hemoglobinopathies
• Embolic disorders
  • Endocarditis
  • Atrial fibrillation
  • Prosthetic mitral valve
  • Paradoxical emboli from right heart
  • Left ventricular mural thrombus following myocardial infarct
  • Infected thoracic aortic graft
  • Human immunodeficiency virus (HIV) – associated mycobacterial infections
• Vascular disorders
• Autoimmune/collagen vascular disease
• Trauma
  • Blunt trauma
  • Torsion of the wandering spleen
  • Left heart catheterization via femoral artery approach
  • Sclerotherapy of bleeding gastric varices
  • Pitressin infusion
  • Embolization for splenic bleeding
• Operative etiologies^6,7
  • Pancreatectomy
  • Liver transplant
• Miscellaneous etiologies
  • Splenic vein thrombosis
  • Pancreatitis
  • Amyloidosis
  • Sarcoidosis
  • Pancreatic cancer
  • Adult respiratory distress syndrome (ARDS)
  • Postpartum toxic shock syndrome

Pathophysiology

• Infiltrative hematologic diseases cause congestion of the splenic circulation by abnormal cells. For instance, the mechanism of splenic infarction in sickle cell disease is attributed to crystallization of the abnormal hemoglobin during periods of hypoxia or acidosis.⁸ The rigid erythrocyte leads to rouleaux formation and occlusion of the splenic circulation. In homozygous sickle cell disease, multiple infarcts during childhood commonly result in a scarred, contracted, auto-infarcted spleen by adulthood. In individuals who are heterozygous for the sickle trait, exposure to low-oxygen tension, such as that which occurs during unpressurized airplane travel, or vigorous activity, such as skiing in high-altitude locations, can precipitate sickling and splenic infarction by the above-described mechanism.⁹ In myelofibrosis, the splenic parenchyma is infiltrated by extramedullary hematopoiesis, causing congestion of the splenic circulation.
• In malignant hematologic diseases (eg, chronic myeloid leukemia), increased splenic oxygen requirements secondary to an increased splenic mass, coupled with a decreased oxygen-carrying capacity secondary to the anemia of hypersplenism, lead to infarction.
• Thromboembolic events are another frequent cause of splenic infarcts.¹⁰ Splenic embolization may result from a variety of cardiovascular conditions, including a left atrial or ventricular mural thrombus that formed as a result of acute myocardial infarction or atrial fibrillation, or that developed from complications of cardiac catheterization or bacterial endocarditis. A report on 108 patients with left-sided endocarditis undergoing valvular surgery revealed a 19% incidence of splenic infarction; in almost half of the study's patients with infarction, the diagnosis was made incidentally on a computed tomography (CT) scan.¹¹
• Another mechanical cause of splenic infarct can be the injection of gastric varices in the setting of portal hypertension and gastric variceal bleeding.¹²
• Hypercoagulable states can cause splenic infarction. For instance, hereditary protein C deficiency has been reported to cause splenic infarction.¹³ Acquired hypercoagulable states include myeloproliferative disorders, lupus anticoagulant, and erythropoietin therapy.
• Splenic infarct has also been reported in association with postpartum toxic shock syndrome.¹⁴
• Splenic vein thrombosis, most commonly the result of pancreatitis or surgery, can result in venous infarction.
• Unusual causes of splenic infarction include malaria, pancreatitis, and cocaine use; it can also occur, uncommonly, as a late complication of liver transplantation.
• The authors have treated 1 case of global splenic infarction in a person with multiple blunt trauma injuries who required hepatic packing as part of a damage control procedure. At the initial exploration, the spleen was intact, perfused, and viable. The patient subsequently required reoperation for release of an intra-abdominal compartment syndrome. Follow-up CT scans after the second operation revealed global splenic infarction, which was attributed to an occlusion of splenic venous outflow due to severe intra-abdominal hypertension and the resultant impedance of venous return from the visceral circulation.
• An anatomic variant that renders the spleen more susceptible to global infarction is that of the wandering spleen.¹⁵ The spleen is attached by a long vascular pedicle, without the usual fixating ligaments to the diaphragm, colon, left kidney, and lateral abdominal wall. This allows torsion of the freely mobile spleen around its vascular pedicle, occluding the blood supply and leading to infarction.

Presentation

• The clinical spectrum varies from asymptomatic infarction (discovered incidentally on radiologic or postmortem studies, or at laparoscopy or laparotomy for another indication) to hemorrhagic shock (secondary to massive subcapsular hemorrhage with free rupture into the peritoneal cavity).
• Approximately one third of splenic infarcts are clinically occult.
• The most common presenting symptom is left – upper quadrant abdominal pain (up to 70%). Additional symptoms include fever and chills, nausea and vomiting, pleuritic chest pain, and left shoulder pain (Kehr sign).
• Septic thromboemboli may result in splenic abscesses, which present with sepsis and left upper abdominal pain.
• In the series from UCLA, most of the patients with thromboembolic infarction were symptomatic; 70% of patients with emboli were febrile, and 86% of individuals with thrombosis had abdominal pain.²

Indications

The indications that warrant surgical intervention include hematologic complications for the underlying disease process and persistent symptoms, such as sepsis, abscess, hemorrhage, or persistent pseudocyst formation. Analysis of operative indications in the UCLA series revealed that patients with hematologic conditions were typically explored for complications of those conditions (69%), especially patients with nonmalignant conditions (90%), while patients with hematologic malignancies often (47%) underwent surgery for acute symptoms.² Complications of splenic infarction were a frequent indication (60%) for operation in patients with septic emboli.²  

Pseudocysts usually are the result of prior trauma, with organization and liquefaction of the resultant hematoma, surrounded by a fibrous pseudocapsule. Small, asymptomatic pseudocysts (< 4cm) usually regress with time, whereas larger splenic cysts (>5 cm) require treatment because the risk of rupture can be as high as 25%.¹⁶  

Splenic abscess can result from septic emboli or superinfection of a prior infarct. These have been managed traditionally by splenectomy, which can be technically challenging due to the intense surrounding inflammation and because of the scar tissue that surrounds the abscess. Indwelling percutaneous catheter drainage and appropriate antibiotic therapy can be used to treat selected cases of well-formed, unilocular abscesses.

Relevant Anatomy

The arterial supply to the spleen consists of the splenic artery (a branch of the celiac axis) and the short gastric arteries (branches of the left gastroepiploic artery), which supply the upper pole of the spleen. Even with occlusion of the main splenic artery, collateral flow from the short gastric arteries often may preserve some or all of the splenic parenchyma.

Within the spleen, the arterial supply is segmental. Occlusion of these secondary branches results in the classic wedge-shaped infarct. Most commonly, these infarcts contract and fibrose over time, as demonstrated by the sickle hemoglobinopathies (in which repeated episodes of infarction ultimately result in auto-infarction of the spleen).

Contraindications

• Asymptomatic infarct without complication does not require surgical intervention.
• Overall, most splenic infarcts do not require surgical intervention.

Workup

Laboratory Studies

• No specific diagnostic laboratory studies for splenic infarction exist, although an elevated white blood cell count is not infrequent.

Imaging Studies

• A CT scan, performed with intravenous, nonionic contrast, is the current diagnostic modality of choice. Prior to the CT scan era, diagnosis of splenic infarct was made most commonly at laparotomy for intra-abdominal catastrophe or on postmortem examination.
• Magnetic resonance imaging (MRI), preferably performed with intravenous gadolinium contrast, is another useful modality that clearly identifies infarcted splenic parenchyma. Contrast-enhanced MRI and multidetector CT scanning allow 3-dimensional reconstructions in any plane (coronal, sagittal, or axial) to better visualize the classic appearance of wedge-shaped infarctions within the spleen.
• Due to the dual blood supply of the spleen, contrast-enhanced studies should be performed during a delayed phase so that the normal early archiform pattern of arterial splenic enhancement does not mask lesions or create pseudolesions. Contrast studies should be performed during an appropriate delay (for patients with good cardiac reserve, 50 seconds is an acceptable scan delay) when most spleens will be in the uniform phase of enhancement.¹⁷  These postcontrast scans clearly depict the classic segmental, wedge-shaped, low-attenuation defect (Figure 3).¹⁸ Less frequently, the entire spleen may be infarcted, leaving only a rim of contrast-enhancing capsule.¹⁹
• Other modes of diagnosis include radioisotope scans and ultrasonographic evaluation of the spleen.
• Angiography is indicated when a vascular lesion is suspected as the etiologic cause, as in cases of arterial embolization, or when it is necessary to manage segmental bleeding by embolization.
• Ultrasonographic imaging is useful in cases in which the splenic parenchyma can be visualized.²⁰ Significant amounts of luminal bowel gas, as well as morbid obesity, render this modality less useful.

Histologic Findings

Pathologic examination of the resected spleen may provide information regarding the pathogenesis of the infarct (eg, evidence of septic or atheromatous emboli or the presence of an infectious etiology).

Treatment

Medical Therapy

Surgery is indicated only in the presence of complications. Otherwise, the infarcted spleen can be left in situ, and the patient is observed. Due to the rarity of this disorder and the largely anecdotal character of many reports, the roles of antibiotics and antiplatelet agents (for the treatment of thrombocytosis) have not been formally addressed. Similarly, no scientifically supported information exists regarding the possible increase in susceptibility to overwhelming postsplenectomy sepsis in these patients.

The principal mainstay of nonoperative therapy is analgesia with either narcotics or nonsteroidal anti-inflammatory agents and close follow-up. Many of the altitude-related episodes in patients with sickle cell disease can be safely treated with supportive care rather than with splenectomy.⁹  Isolated splenic abscess can in certain circumstances be treated with percutaneous drainage alone, and splenectomy can be avoided. However, a patient with multiple splenic abscesses usually will require splenectomy.

Surgical Therapy

• For an infarcted spleen with any of the above-mentioned complications, splenectomy is required.
• Because of the (albeit small) risk of fatal, overwhelming postsplenectomy sepsis, splenic preservation is preferable whenever possible.
• In cases of torsion of a wandering spleen, splenopexy with splenic salvage is the procedure of choice in the well-perfused, noninfarcted spleen. Techniques include suturing the spleen to the surrounding structures, wrapping the organ in omentum or mesh prior to suture fixation, or placing it in a surgically created retroperitoneal pouch. This has been reported laparoscopically.²¹
• Complications, such as bleeding or pseudocyst formation, also may be amenable to splenic salvage using techniques of partial splenectomy.
• While a unilocular abscess can be managed successfully in select cases with percutaneous catheter drainage, some authors advocate splenectomy in all cases of splenic infarct and abscess, questioning the utility of preserving the residual, partially functioning spleen. This may be accomplished using traditional open techniques or with laparoscopic techniques.
• Perisplenic inflammation and dense adhesions can make splenectomy difficult. Another choice is to perform preoperative splenic artery embolization; this purposely infarcts the remaining spleen and minimizes blood loss, which otherwise can be quite profuse in these difficult dissections. Intraoperative ligation of the splenic artery at the superior margin of the pancreas in the lesser sac is another alternative to minimize blood loss if the spleen is enlarged.

Preoperative Details

• The choice of preoperative antibiotics should be guided by the patient's clinical status and associated comorbidities. A first-generation cephalosporin usually is adequate.
• Appropriate preoperative hydration is essential in anticipation of potential blood loss.
• If splenectomy (rather than splenic preservation) is planned, the patient should receive the pneumococcal and Haemophilus influenza vaccine at least 2 weeks prior to the operation, if feasible. 
• Neoadjuvant chemotherapy in patients with hematologic malignancies (eg, chronic myeloid leukemia) can reduce spleen size and potentially increase the safety of the procedure.
• Preoperative sequential compression devices and subcutaneous heparin can be used for deep venous thrombosis (DVT) prophylaxis.

Intraoperative Details

• The approach (eg, laparoscopy, midline laparotomy, or left subcostal incision) is determined by the underlying pathology/clinical scenario, as well as by the surgeon's preference. The presence of splenic infarct (or abscess) is not per se a contraindication for laparoscopy. Generally, the laparoscopic approach is contraindicated in emergent situations, such as hemorrhagic shock and spontaneous rupture. The surgeon's experience determines the point at which the enlarged spleen is too large to remove laparoscopically.
• For the laparoscopic approach, patient position is key to the success of this operation. Choices include the "hanging spleen" technique, in which the patient is in the lateral decubitus position (as described for laparoscopic adrenalectomy). Another option is the "leaning spleen" technique, in which the patient is at a 45 º tilt. Both methods require a beanbag or jelly roll positioning pad. Once pneumoperitoneum is established, the splenocolic ligament is usually divided with ultrasonic shears. Next, the lesser sac is entered, and the short gastric vessels are divided.
  
  If the surgeon prefers to "preligate," the splenic artery can be dissected along the superior border of the pancreas and can be divided with the vascular stapler. Otherwise, if feasible, the splenic vein and artery are exposed first and are dissected 1 cm proximal to the hilum, and they are usually divided with the vascular stapler. Then, the remainder of the spleen is released by dividing the peritoneal attachments with the ultrasonic scalpel. In other scenarios, the attachments are divided first and the spleen is rolled anteriorly to expose the tail of the pancreas and the hilar vessels posteriorly. These vessels are then transected with the laparoscopic vascular stapler. The spleen is placed into an EndoCatch bag and is morcellated and extracted through the largest trocar site.
  
  Other laparoscopic approaches are the supine approach (with set-up similar to laparoscopic Nissen fundoplication) and the hand-assisted approach.
• For the open approach, a standard midline incision or left subcostal incision (with possible Kehr extension up to the xiphocostal junction) may be used. Placing a large roll under the left flank often aids in exposure. Usually, the gastrocolic ligament is opened outside the gastroepiploic arcade and the splenic artery is identified along the superior border of the pancreas and then ligated. Next, the spleen is completely mobilized by dividing the avascular splenophrenic and splenorenal ligaments. The splenocolic ligament is divided, and the spleen is mobilized into the wound. The tail of the pancreas is separated from the splenic artery and vein, the splenic vessels are ligated, and the spleen is extracted.
• Laparoscopic or open partial splenectomy should be attempted when feasible, due to the risk of lifelong susceptibility to infectious complications after splenectomy, particularly the rare, but highly fatal, overwhelming postsplenectomy sepsis. There are several techniques described for splenic repair.¹⁶  The critical intraoperative maneuver regarding intraoperative splenic salvage entails fully mobilizing the spleen into the wound; this requires the division of 1 or 2 of the short gastric vessels combined with gentle dissection posteriorly, so that the capsule is not torn in the mobilization process.⁵  Laparoscopic partial splenectomy also has been described, including for splenic abscess, using the ultrasonic scalpel or radiofrequency ablation for parenchymal division.^22,23
• The use of postoperative drainage depends on the operative findings, including the presence of a frank abscess, and the proximity of the dissection to the pancreatic tail. The authors' preference is for closed suction drainage to be placed in the splenic bed, with early removal (ie, within 24 hours). There is some evidence that the routine use of drainage of the splenic bed in the absence of extrasplenic abscess or pancreatic injury is associated with an increased risk of local infection.
• If concern exists regarding possible impingement upon the gastric wall during short gastric vessel division, a nasogastric tube may be left in place.

Postoperative Details

• Following splenectomy or global infarct, administer pneumococcal vaccine (Pneumovax) and vaccine against Haemophilus (if not given preoperatively).
• Postoperative thrombocytosis occurs frequently. Antiplatelet therapy is initiated for platelet counts of greater than 1 million/mm³. However, antiplatelet therapy is controversial in this circumstance, and its benefit has not been demonstrated with a randomized, prospective, controlled trial.
• The authors' current preferences for DVT prophylaxis are the use of sequential compression devices prior to incision and the postoperative employment of early ambulation and subcutaneous heparin.
• Postoperative pain management may include intravenous PCA and possible epidural for cases requiring laparotomy.

Follow-up

Follow-up is directed by the underlying cause of the infarction or abscess rather than by the absence of the spleen. Patients undergoing nonoperative management of splenic infarct, particularly a large infarct (when there is a concern that it will rupture), should be followed closely, with a low threshold for serial imaging.

Complications

• Pulmonary: pulmonary complications (e.g., pneumonia, atelectasis, etc.) were the most frequent complication (20%) in the UCLA series.²   With the current trend of laparoscopic approach to splenectomy and partial splenectomy, this complication rate should be significantly reduced.
• Infections - Postoperative abscess, fever, and wound infection are the second-most common complication (~10%). The first line of treatment is radiologically guided percutaneous drainage and antibiotics. A missed injury to a viscus (eg, stomach or colon) should be ruled out.
• Hemorrhage - Hemorrhage, although relatively infrequent, can follow splenectomy due to the intense perisplenic inflammation. 
• Pancreatic fistula - Because of the intimate association of the pancreatic tail and the splenic hilum, pancreatic injury can occur, especially in the setting of intense inflammation and/or abscess. The majority of these injuries resolve with nonoperative management, which includes wide drainage, the use of a somatostatin analogue to decrease exocrine pancreatic function, and either total parenteral nutrition (TPN) or enteral alimentation distal to the ligament of Treitz.
• Gastric fistula - Due to the intense inflammatory reaction that can accompany splenic abscess, the dissection of the spleen from the greater curve of the stomach can be difficult, and inadvertent, unrecognized injuries to the greater curve of the stomach do occur. With adequate external drainage and with no obstruction to normal gastric emptying, these can be treated expectantly with TPN or distal luminal alimentation and nasogastric tube decompression.
• Overwhelming postsplenectomy sepsis - This is the most serious postsplenectomy complication; it occurs rarely (0.5%) in adult patients but carries a prohibitive mortality in unvaccinated patients. For this reason, a trend away from splenectomy and toward splenic conservation has emerged.

Outcome and Prognosis

The prognosis varies with the underlying disease process responsible for splenic infarction. Splenectomies for infarction of massively enlarged spleens accompanying hematologic malignancies have reported mortality rates of as high as 35%. At the other end of the spectrum, many infarcts are clinically occult, with no significant long-term sequelae.

Asplenic individuals have an increased lifetime risk for developing overwhelming postsplenectomy sepsis, with the highest rate in the pediatric age group. Patients should be counseled to seek medical attention even for seemingly minor infections, because these can progress to fatal septicemia within hours.

These considerations have proven to be the impetus for splenic preservation.

Future and Controversies

As laparoscopic techniques become more advanced, many of these surgical problems certainly will be amenable to laparoscopic splenectomy or partial splenectomy. There is great interest regarding the extension of the safe indications for splenic preservation. As technologies evolve, laparoscopic splenic preservation may become the future standard of care for segmental infarcts. 

Multimedia

Media file 1: Splenic infarct. Computed tomography scan of a 51-year-old man following a motor vehicle accident. American Association for the Surgery of Trauma (AAST) grade III splenic injury, with active extravasation of contrast from the splenic parenchyma (the white area along the medial aspect of the spleen).

Media file 2: Splenic infarct. Selective splenic arteriogram showing extravasation of contrast from the splenic artery at the splenic hilum prior to angioembolization (see Image 3).

Media file 3: Computed tomography scan of the spleen 5 days after angioembolization of a bleeding splenic artery, showing partial splenic infarct (demonstrated by a lack of IV contrast enhancement of the lower pole of spleen). The patient experienced no adverse sequelae and fared well following his discharge to home 5 days after the embolization (see Image 2).

References

1. Edinburgh Med J. 1905;36.

2. Nores M, Phillips EH, Morgenstern L. The clinical spectrum of splenic infarction. Am Surg. Feb 1998;64(2):182-8. [Medline].

3. Jaroch MT, Broughan TA, Hermann RE. The natural history of splenic infarction. Surgery. Oct 1986;100(4):743-50. [Medline].

4. Joshi SC, Pant I, Shukla AN, et al. Splenic infarct as a diagnostic pitfall in radiology. J Cancer Res Ther. Apr-Jun 2008;4(2):99-101. [Medline].

5. Pachter HL, Guth AA, Hofstetter SR. Changing patterns in the management of splenic trauma: the impact of nonoperative management. Ann Surg. May 1998;227(5):708-17; discussion 717-9. [Medline]. [Full Text].

6. Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. Jun 2008;95(6):744-50. [Medline].

7. Wu SC, Chen RJ, Yang AD, et al. Complications associated with embolization in the treatment of blunt splenic injury. World J Surg. Mar 2008;32(3):476-82. [Medline].

8. Franklin QJ, Compeggie M. Splenic syndrome in sickle cell trait: four case presentations and a review of the literature. Mil Med. Mar 1999;164(3):230-3. [Medline].

9. Sheikha A. Splenic syndrome in patients at high altitude with unrecognized sickle cell trait: splenectomy is often unnecessary. Can J Surg. Oct 2005;48(5):377-81. [Medline]. [Full Text].

10. O'Keefe JH Jr, Holmes DR Jr, Schaff HV, et al. Thromboembolic splenic infarction. Mayo Clin Proc. Dec 1986;61(12):967-72. [Medline].

11. Ting W, Silverman NA, Arzouman DA, et al. Splenic septic emboli in endocarditis. Circulation. Nov 1990;82(5 Suppl):IV105-9. [Medline].

12. Yu LK, Hsu CW, Tseng JH, et al. Splenic infarction complicated by splenic artery occlusion after N-butyl-2-cyanoacrylate injection for gastric varices: case report. Gastrointest Endosc. Feb 2005;61(2):343-5. [Medline].

13. Olson JF, Steuber CP, Hawkins E, et al. Functional deficiency of protein C associated with mesenteric venous thrombosis and splenic infarction. Am J Pediatr Hematol Oncol. Summer 1991;13(2):168-71. [Medline].

14. Torda A. Postpartum toxic shock syndrome associated with multiple splenic infarcts. Med J Aust. 2005;182:93. [Medline]. [Full Text].

15. Desai DC, Hebra A, Davidoff AM. Wandering spleen: a challenging diagnosis. South Med J. Apr 1997;90(4):439-43. [Medline].

16. Pachter HL, Hofstetter SR, Elkowitz A. Traumatic cysts of the spleen--the role of cystectomy and splenic preservation: experience with seven consecutive patients. J Trauma. Sep 1993;35(3):430-6. [Medline].

17. Urban BA, Fishman EK. Helical CT of the spleen. AJR Am J Roentgenol. Apr 1998;170(4):997-1003. [Medline]. [Full Text].

18. Balcar I, Seltzer SE, Davis S. CT patterns of splenic infarction: a clinical and experimental study. Radiology. Jun 1984;151(3):723-9. [Medline]. [Full Text].

19. Kluger Y, Paul DB, Townsend RN. Enhanced rim around infarcted, traumatized spleen on computed tomographic scans: case report. J Trauma. Mar 1994;36(3):436-7. [Medline].

20. Goerg C, Schwerk WB. Splenic infarction: sonographic patterns, diagnosis, follow-up, and complications. Radiology. Mar 1990;174(3 Pt 1):803-7. [Medline]. [Full Text].

21. Cavazos S, Ratzer ER, Fenoglio ME. Laparoscopic management of the wandering spleen. J Laparoendosc Adv Surg Tech A. Aug 2004;14(4):227-9. [Medline].

22. De Greef E, Hoffman I, Topal B, et al. Partial laparoscopic splenectomy for splenic abscess because of Salmonella infection: a case report. J Pediatr Surg. May 2008;43(5):E35-8. [Medline].

23. Héry G, Becmeur F, Méfat L, et al. Laparoscopic partial splenectomy: indications and results of a multicenter retrospective study. Surg Endosc. Jan 2008;22(1):45-9. [Medline].

Keywords

splenic infarction, spleen, infarction, infarct, splenic, splenectomy, segmental splenic infarct, global splenic infarct, splenic hemorrhage, splenic rupture, splenic abscess, splenic pseudocyst

Contributor Information and Disclosures

Author

Manish Parikh, MD, Assistant Professor of Surgery, Department of Surgery, New York University School of Medicine; Attending Surgeon, Director Laparoscopic and Bariatric Surgery, Bellevue Hospital
Manish Parikh, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, and Society of American Gastrointestinal and Endoscopic Surgeons
Disclosure: Nothing to disclose.

Coauthor(s)

H Leon Pachter, MD, FACS, Chair, George David Stewart Professor, Department of Surgery, New York University Medical Center
H Leon Pachter, MD, FACS is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, American Surgical Association, American Trauma Society, New York Academy of Sciences, Society for Surgery of the Alimentary Tract, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

Lewis J Kaplan, MD, FACS, FCCM, FCCP, Director, SICU and Surgical Critical Care Fellowship, Associate Professor, Department of Surgery, Section of Trauma, Surgical Critical Care, and Surgical Emergencies, Yale University School of Medicine
Lewis J Kaplan, MD, FACS, FCCM, FCCP is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, Association for Academic Surgery, Association for Surgical Education, Connecticut State Medical Society, Eastern Association for the Surgery of Trauma, International Trauma Anesthesia and Critical Care Society, Society for the Advancement of Blood Management, Society of Critical Care Medicine, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Amy L Friedman, MD, Professor of Surgery, Director of Transplantation, State University of New York Upstate Medical University College of Medicine, Syracuse
Amy L Friedman, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Medical Women's Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, American Society of Transplantation, Association for Academic Surgery, Association of Women Surgeons, International College of Surgeons, International Liver Transplantation Society, New York Academy of Sciences, Pennsylvania Medical Society, Philadelphia County Medical Society, Society of Critical Care Medicine, and Transplantation Society
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other

We wish to thank Amber A Guth, MD, FACS, Associate Professor, Department of Surgery, New York University Clinical Cancer Center, New York University School of Medicine, for her contribution to this article.

Related eMedicine topics:
Endocarditis
Endocarditis, Bacterial
Sickle Cell Anemia [Hematology]
Sickle Cell Disease [Ophthalmology]
Sickle Cell Anemia [Pediatrics: General Medicine]
Spleen, Trauma
Splenic Abscess

© 1994- by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)